GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » Debt-to-Revenue

Touyun Biotech Group (HKSE:01332) Debt-to-Revenue : 2.02 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Touyun Biotech Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$179.4 Mil. Touyun Biotech Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$205.6 Mil. Touyun Biotech Group's annualized Revenue for the quarter that ended in Dec. 2023 was HK$190.5 Mil. Touyun Biotech Group's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 2.02.


Touyun Biotech Group Debt-to-Revenue Historical Data

The historical data trend for Touyun Biotech Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group Debt-to-Revenue Chart

Touyun Biotech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 1.07 1.12 1.25 1.94

Touyun Biotech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.09 1.32 1.78 2.02

Competitive Comparison of Touyun Biotech Group's Debt-to-Revenue

For the Packaging & Containers subindustry, Touyun Biotech Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touyun Biotech Group's Debt-to-Revenue Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's Debt-to-Revenue falls into.



Touyun Biotech Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Touyun Biotech Group's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(179.355 + 205.554) / 198.64
=1.94

Touyun Biotech Group's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(179.355 + 205.554) / 190.546
=2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


Touyun Biotech Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Touyun Biotech Group (HKSE:01332) Business Description

Traded in Other Exchanges
N/A
Address
6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines